VEGFR2/CD309 anticorps
Aperçu rapide pour VEGFR2/CD309 anticorps (ABIN2477091)
Antigène
Voir toutes VEGFR2/CD309 (VEGFR2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Attributs du produit
- Purified IgG
-
Purification
- Purified
-
Immunogène
- Synthetic peptide: internal domain of human VEGF receptor 2, conjugated to Keyhole Limpet Hemocyanin (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
-
-
: "Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis." dans: Journal of biochemistry and molecular biology, Vol. 39, Issue 5, pp. 469-78, (2006) (PubMed).
-
: "Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis." dans: Journal of biochemistry and molecular biology, Vol. 39, Issue 5, pp. 469-78, (2006) (PubMed).
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Autre désignation
- VEGF RECEPTOR 2
-
Sujet
- Synonyms: KDR
-
ID gène
- 3791
-
UniProt
- P35968
-
Pathways
- Signalisation RTK, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Antigène
-